Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 14, 2026
Salesforce (CRM) Climbs +26% Over 30 Days on AI Momentum

Salesforce (CRM) Climbs +26% Over 30 Days on AI Momentum

Key Takeaways

  • Salesforce (CRM) climbed roughly 26% over the last 30 days, rising from about $196 in mid-August to around $248 by mid-September.
  • The move was driven primarily by fiscal Q2 2027 results reported on August 26, 2026, which beat estimates and included a raised full-year outlook.
  • Agentic AI momentum was a central catalyst, with Agentforce ARR exceeding $1.5 billion and combined AI/data ARR approaching $3.9 billion.
  • Over the trailing quarter, CRM rebounded roughly 50% from a mid-June low near $150.
  • Profitability received a boost from a $2.6 billion gain on strategic investments, lifting non-GAAP EPS to $5.90 versus a $3.27 consensus estimate.

Company Background and Competitive Standing

Salesforce, Inc. stands as one of the largest enterprise software providers globally and the leading supplier of customer relationship management software. Its offerings cover Sales Cloud, Service Cloud, Marketing Cloud, Commerce Cloud, Data Cloud, Tableau, MuleSoft, and Slack. The firm has shifted focus toward agentic artificial intelligence via the Agentforce platform, enabling businesses to implement AI agents for automating service, sales, and operational tasks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

While facing competition from hyperscalers and other software vendors, Salesforce benefits from its large installed base, broad distribution, recurring revenue model, and growing data and AI capabilities. The stock serves as a key indicator for enterprise software demand and the pace of AI monetization at the application level.

30-Day Price Movement Compared to the Quarter

Over the past 30 days, CRM advanced about 26.3%, moving from a close of $196.21 on August 14, 2026, to $247.72 on September 11, 2026. Most of the advance occurred in one session after the company released second-quarter results on August 26, when the stock rose roughly 22.6% from $205.62 to $252.05 on August 27. Shares later reached the $268 area in early September before easing back into the mid-$240s.

From a quarterly perspective the advance looks even more pronounced. After touching lows near $150 in late June, the stock recovered through July and then accelerated following the earnings release. From a mid-June close around $165, CRM has risen about 50% to present levels, marking a clear change in sentiment around its AI strategy and growth path.

Factors Behind the Recent 30-Day Gains

The main driver was Salesforce’s fiscal 2027 second-quarter earnings. Revenue increased 11% year over year to $11.35 billion, while non-GAAP earnings per share reached $5.90, well above the $3.27 consensus. A $2.61 billion gain on strategic investments added $2.53 per share to the non-GAAP result.

Guidance also supported the move. Management raised full-year revenue expectations to $46.1 billion–$46.4 billion and lifted non-GAAP EPS guidance to $16.67–$16.71. Current remaining performance obligation grew 14% in constant currency to $33.5 billion.

AI metrics added further support. Agentforce ARR surpassed $1.5 billion, up more than 240% year over year, while combined Agentforce and Data 360 ARR approached $3.9 billion. Customers ran 3.2 billion Agentic Work Units in the quarter, up 97% sequentially. The company also noted a partnership with Anthropic to develop “Cloudforce,” an AI offering that pairs Anthropic’s models with Salesforce’s CRM platform.

Quarterly Rebound and Sentiment Shift

The three-month trend reflects changing investor views on Salesforce’s growth and AI positioning. The stock declined through mid-June before bottoming near $150 amid concerns over enterprise software demand. Sentiment improved through July as the company demonstrated progress on bookings, net new annual order value, and customer retention.

The August earnings report reinforced the turnaround. Salesforce posted its strongest net new annual order value growth in four years and attrition at record lows, countering earlier worries about a SaaS slowdown. Together with faster AI adoption and higher guidance, these results supported a sustained re-rating of the stock into September. From what I see, this reversal highlights how quickly views can shift when results align with AI expectations.

Key Items to Monitor Going Forward

Attention will turn to Salesforce’s fiscal Q3 2027 results, expected around early December 2026, for signs that revenue reacceleration and AI adoption remain intact. Management guided to Q3 revenue of $11.42 billion–$11.50 billion and non-GAAP EPS of $3.42–$3.44, with cRPO growth around 14% in constant currency.

Items to track include Agentforce monetization, the launch of the Anthropic-powered Cloudforce offering, uptake of outcome-based and consumption-based pricing, and completion of the pending Contentful and Fin acquisitions. Broader factors such as currency movements, enterprise IT spending, and competition from other AI platforms will also matter. I’m watching this closely as the next few quarters should clarify whether the recent momentum holds.

AI Tools in Portfolio Monitoring

In my own research I sometimes review Tickeron’s AI Trend Prediction Engine to cross-check momentum signals across sectors. The platform’s pattern recognition features have helped me compare Salesforce’s setup with peers, providing an additional data point alongside traditional analysis. It is not a replacement for fundamental work but serves as a useful supplement when evaluating entry or exit levels.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for CRM turns negative, indicating new downward trend

CRM saw its Momentum Indicator move below the 0 level on September 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 58 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CRM moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 14 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 60 cases where CRM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for CRM turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 30 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

CRM broke above its upper Bollinger Band on August 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +0.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in 225 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 145 of 215 cases where CRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.313) is normal, around the industry mean (28.430). P/E Ratio (22.685) is within average values for comparable stocks, (75.733). Projected Growth (PEG Ratio) (0.827) is also within normal values, averaging (1.599). Dividend Yield (0.007) settles around the average of (0.048) among similar stocks. P/S Ratio (5.048) is also within normal values, averaging (78.048).

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 99 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Atlassian Corp (NASDAQ:TEAM), Workday (NASDAQ:WDAY), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.01B. The market cap for tickers in the group ranges from 291 to 237.52B. SAP holds the highest valuation in this group at 237.52B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -4%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 3%. FTFT experienced the highest price growth at 77%, while AIXI experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
CRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-demand customer relationship management software technology

Industry PackagedSoftware

Profile
Details
Industry
Packaged Software
Address
415 Mission Street
Phone
+1 415 901-7000
Employees
83334
Web
https://www.salesforce.com
Interact to see
Advertisement
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.
NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.